×
About 50 results

ALLMedicine™ Drug-induced Lupus Erythematosus Center

Research & Reviews  20 results

The clinical significance of spondin 2 eccentric expression in peripheral blood mononuc...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183911
Journal of Clinical Laboratory Analysis; Zhou P, Xiang CX et. al.

May 18th, 2021 - Bronchial asthma (BA) was a heterogeneous disease characterized by chronic airway inflammation. Spondin 2 (SPON2) was reported to be implicated in the integrin pathway, protein metabolism, and drug-induced lupus erythematosus. The purpose of this ...

Antinuclear antibody (ANA) monitoring in drug-induced lupus erythematosus (DILE).
https://doi.org/10.1093/rheumatology/keaa883
Rheumatology (Oxford, England); Lee AYS, Gordon TP

Dec 29th, 2020 - Antinuclear antibody (ANA) monitoring in drug-induced lupus erythematosus (DILE).|2020|Lee AYS,Gordon TP,|

Antithyroid Drug-Induced Lupus Erythematosus and Immunoglobulin A Deficiency.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767573
The American Journal of Case Reports; Beernaert L, Vanderhulst J

Dec 23rd, 2020 - BACKGROUND Antithyroid drugs, namely methimazole, are well-known causes of drug-induced lupus erythematosus. This is, however, an infrequent adverse effect. Selective Immunoglobulin A (IgA) deficiency, in contrast, is the most common primary immun...

Complication of Mycobacterium tuberculosis treatment: Isoniazid-induced pneumonitis.
https://doi.org/10.1016/j.ijid.2020.09.1431
International Journal of Infectious Diseases : IJID : Off... Adkinson BC, De La Fuente J et. al.

Sep 29th, 2020 - Prolonged therapy with isoniazid is used for the treatment of pulmonary tuberculosis. Drug-induced lupus erythematosus is a rare, adverse event associated with isoniazid use and can complicate treatment, especially if it is associated with pneumon...

Association Between Drug Use and Subsequent Diagnosis of Lupus Erythematosus.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489398
JAMA Dermatology; Haugaard JH, Kofoed K et. al.

Sep 3rd, 2020 - It has been estimated that up to 30% of all subacute cutaneous lupus erythematosus (CLE) cases and up to 15% of systemic lupus erythematosus (SLE) cases are drug induced. Based on numerous case reports and several epidemiologic studies, more than ...

see more →